Chemotherapy
Country
Switzerland
Western Europe
Subject Area and Category
Medicine
└
Drug Discovery
Q3
└
Infectious Diseases
Q3
└
Medicine (miscellaneous)
Q3
Publisher
SJR 2025
0.442
Q3
SJR Score
H-Index
64
Citations / Doc (2yr)
1.10
Total Docs. (latest)
21
Total Citations (3yr)
124
Publication type
Journals
ISSN
00093157, 14219794
Coverage
1960-2025
Journal Rank
#13,194
Subject Categories
Drug Discovery
Q3
Infectious Diseases
Q3
Medicine (miscellaneous)
Q3
Oncology
Q3
Pharmacology
Q3
Pharmacology (medical)
Q3
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 21 |
| Total Docs. (3 years) | 89 |
| Total Refs. | 822 |
| Total Citations (3 years) | 124 |
| Citable Docs. (3 years) | 87 |
| Citations / Doc. (2 years) | 1.10 |
| Ref. / Doc. | 39.14 |
| % Female | 44.8% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Chemotherapy?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Chemotherapy has an SJR of 0.442 and is ranked Q3.
What is the SJR and quartile of Chemotherapy?
Chemotherapy has an SJR (SCImago Journal Rank) of 0.442 and its best quartile is Q3.
What is the H-index of Chemotherapy?
The H-index of Chemotherapy is 64, meaning 64 of its articles have each been cited at least 64 times.
Is Chemotherapy indexed in Scopus?
Yes. Chemotherapy is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.